Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Embla Medical - Recording of Q2 2025 results presentation

By Michael FriisHead of Equities
Embla Medical

Today, Embla Medical's CEO, Sveinn Sölvason, presented the Q2/H1 2025 results, along with an update to the 2025 guidance, in which the company revised down the top of its growth expectations.

He also discussed the strategic rationale behind the latest acquisition. During the Q&A session, the focus, among other topics, was on the potential effects of tariffs and the impact of the new political landscape.

You can watch a recording of the presentation here: https://www.inderes.dk/videos/embla-medical-presentation-of-q2-2025-interim-report

Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR agreement. /Michael Friis 13:30, 22/07/2025.

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.